Potential molecular prognostic factors in nonsmall cell lung cancer patients treated with Gefitinib

被引：0
|
作者：
Polowy, CR [1 ]
Coon, J [1 ]
Qawi, H [1 ]
Villaflor, VM [1 ]
Leslie, W [1 ]
Lukic, I [1 ]
Kanevsky, G [1 ]
Gale, M [1 ]
Stewart, I [1 ]
Bonomi, P [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL 60612 USA
来源：
LUNG CANCER | 2004年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S54 / S55
页数：2
相关论文
共 50 条
  • [1] Prognostic Model to Predict Outcomes in Nonsmall Cell Lung Cancer Patients Treated With Gefitinib as a Salvage Treatment
    Park, Min Jae
    Lee, Jeeyun
    Hong, Jung Yong
    Choi, Moon Ki
    Yi, Joon Ho
    Lee, Su Jin
    Oh, Suk Joong
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung Ju
    CANCER, 2009, 115 (07) : 1518 - 1530
  • [2] Potential clinical prognostic factors in non-small cell lung cancer (NSCLC) patients treated with Gefitinib (Iressa)
    Villaflor, VM
    Polowy, CR
    Coon, J
    Leslie, W
    Lukic, I
    Kanevsky, G
    Gale, M
    Stewart, I
    Bonomi, P
    LUNG CANCER, 2004, 46 : S62 - S62
  • [3] Potential clinical prognostic factors in non-small cell lung cancer (NSCLC) patients treated with gefitinib.
    Villaflor, VM
    Polowy, CR
    Coon, JS
    Leslie, WT
    Lukic, I
    Kanevsky, G
    Gale, M
    Stewart, I
    Bonomi, P
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 638S - 638S
  • [4] PROGNOSTIC FACTORS IN LOCOREGIONAL NONSMALL CELL LUNG-CANCER TREATED WITH RADIOTHERAPY
    COEN, V
    VANLANCKER, M
    DENEVE, W
    STORME, G
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (02): : 111 - 117
  • [5] BIOLOGIC AND MOLECULAR PROGNOSTIC FACTORS - IMPACT ON TREATMENT OF PATIENTS WITH NONSMALL CELL LUNG-CANCER
    JOHNSON, BE
    CHEST, 1995, 107 (06) : S287 - S290
  • [6] Clinical factors affecting acquired resistance to gefitinib in previously treated Japanese patients with advanced nonsmall cell lung cancer
    Segawa, Yoshihiko
    Hotta, Katsuyuki
    Umemura, Shigeki
    Fujiwara, Yoshiro
    Shinkai, Tetsu
    Ueoka, Hiroshi
    Takigawa, Nagio
    Tabata, Masahiro
    Kiura, Katsuyuki
    Tanimoto, Mitsune
    CANCER, 2006, 107 (08) : 1866 - 1872
  • [7] PROGNOSTIC FACTORS IN NONSMALL CELL LUNG-CANCER
    FELD, R
    BORGES, M
    GINER, V
    GINSBERG, R
    HARPER, P
    KLASTERSKY, J
    LACQUET, L
    PAESMANS, M
    PAYNE, D
    ROSELL, R
    SAUSE, W
    SCULIER, JP
    SHAW, E
    SORENSEN, JB
    SPLINTER, T
    STAHEL, R
    BUNN, P
    LUNG CANCER, 1994, 11 : S19 - S23
  • [8] BIOLOGICAL PROGNOSTIC FACTORS IN NONSMALL CELL LUNG-CANCER
    SCAGLIOTTI, GV
    MASIERO, P
    POZZI, E
    LUNG CANCER, 1995, 12 : S13 - S25
  • [9] Prognostic Model to Predict Outcomes in Nonsmall Cell Lung Cancer Patients Treated With Gefitinib as a Salvage Treatment (vol 115, pg 1518, 2009)
    Park, M. J.
    Lee, J.
    Hong, J. Y.
    Choi, M. K.
    Yi, J. H.
    Lee, S. J.
    Oh, S. J.
    Ahn, J. S.
    Park, K.
    Ahn, M. J.
    CANCER, 2009, 115 (09) : 2023 - 2023
  • [10] Two radiation regimens and prognostic factors for brain Metastases in nonsmall cell lung cancer patients
    Rades, Dirk
    Schild, Steven E.
    Lohynska, Radka
    Veninga, Theo
    Stalpers, Lukas J. A.
    Dunst, Juergen
    CANCER, 2007, 110 (05) : 1077 - 1082
12345